These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2467089

  • 1. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
    Grover GJ, Schumacher WA, Simon M, Parham C.
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
    [Abstract] [Full Text] [Related]

  • 2. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs.
    Grover GJ, Schumacher WA.
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253
    [Abstract] [Full Text] [Related]

  • 3. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    Grover GJ, Schumacher WA.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
    [Abstract] [Full Text] [Related]

  • 4. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
    Grover GJ, Schumacher WA.
    Basic Res Cardiol; 1989 Feb; 84(1):103-10. PubMed ID: 2522297
    [Abstract] [Full Text] [Related]

  • 5. Effect of thromboxane receptor blockade on oxygen supply/consumption variables during reperfusion in the anesthetized dog.
    Grover GJ, Sleph PG, Weiss HR.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1097-102. PubMed ID: 2141635
    [Abstract] [Full Text] [Related]

  • 6. Myocardial salvage efficacy of a thromboxane receptor antagonist, SQ, 30,741, in relation to inhibition ex vivo of platelet function in the ferret.
    Gomoll AW, Ogletree ML.
    Prostaglandins; 1993 Sep; 46(3):233-42. PubMed ID: 8234831
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT.
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [Abstract] [Full Text] [Related]

  • 8. The role of thromboxane A2 in reperfusion injury.
    Grover GJ, Sleph PG, Parham C.
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):504-8. PubMed ID: 2971219
    [Abstract] [Full Text] [Related]

  • 9. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
    Grover GJ, Parham CS, Schumacher WA.
    Basic Res Cardiol; 1991 Sep; 86(2):99-106. PubMed ID: 1831610
    [Abstract] [Full Text] [Related]

  • 10. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P, Ambrosio G, Villari B, Ragni M, Focaccio A, Pace L, de Clerk F, Condorelli M, Chiariello M.
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [Abstract] [Full Text] [Related]

  • 11. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P, Rosolowsky M, Yao SK, McNatt J, De Clerck F, Buja LM, Willerson JT.
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [Abstract] [Full Text] [Related]

  • 12. Thromboxane receptor blockade with SQ 30,741 improves post-ischemic myocardial function in anesthetized dogs.
    Grover GJ.
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):56-60. PubMed ID: 2529546
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
    Ogletree ML, Harris DN, Heran CL, Phillips MB, Michel IM, Goldenberg HJ.
    Eicosanoids; 1988 Oct; 1(2):85-91. PubMed ID: 2856188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
    Vandeplassche G, Hermans C, Somers Y, Van de Werf F, de Clerck F.
    J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
    [Abstract] [Full Text] [Related]

  • 18. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA, Heran CL, Ogletree ML.
    Eicosanoids; 1990 Apr; 3(2):87-93. PubMed ID: 2144979
    [Abstract] [Full Text] [Related]

  • 19. Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemia.
    Grover GJ, Parham CS.
    Circ Res; 1989 Mar; 64(3):575-82. PubMed ID: 2917381
    [Abstract] [Full Text] [Related]

  • 20. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
    McMahon TJ, Hood JS, Nossaman BD, Ibrahim IN, Feng CJ, Kadowitz PJ.
    J Appl Physiol (1985); 1991 Nov; 71(5):2012-8. PubMed ID: 1837015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.